ESC 365 - The soluble IL6 receptor and ischemic cerebrovascular disease

ESC Premium Access

The soluble IL6 receptor and ischemic cerebrovascular disease

Session: Poster Session 3 - Peripheral vascular and cerebrovascular disease: pathophysiology

Topic: Pathophysiology and Mechanisms

Speaker: Doctor L. Ziegler (Stockholm, SE)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Louise Ziegler

Karolinska Institute, Stockholm (Sweden)

1 presentation

0 follower

7 more presentations in this session

Arginase inhibition improves endothelial function in patients with type 2 diabetes mellitus despite intensive glucose lowering therapy

Speaker: Mr A. Mahdi (Stockholm, SE)

The associations between the effect of cilostazol on the proprotein convertase subtilisin/kexin type 9 concentrations and circulating endothelial progenitor cells and vasculo-angiogenesis factors

Speaker: Professor T. Chao (Tainan, TW)

Improvement of endothelial glycocalyx thickness after anti-inflammatory treatment is related with reduced arterial blood pressure, stiffness and wave reflections in psoriasis.

Speaker: Doctor I. Ikonomidis (Athens, GR)

Ageing-related endothelial dysfunction in the femoral vein is mediated by cyclooxygenases: Role of thromboxane prostanoid receptors

Speaker: Doctor S. Gaertner (Strasbourg, FR)

Transferrin receptor 1 hetero deletion attenuates angiogenesis in mouse hind limb ischemia model

Speaker: Doctor K. Okuno (Philadelphia, US)

Access the full session

Poster Session 3 - Peripheral vascular and cerebrovascular disease: pathophysiology

Speakers: Doctor L. Ziegler, Mr A. Mahdi, Professor T. Chao, Doctor I. Ikonomidis, Doctor S. Gaertner...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources